EviCore Announces Positive Coverage Guidelines For Heartflow Plaque Analysis To Extensive Network Of Commercial Payers. Click to read press release.

Heartflow In The News

Newsroom
Heartflow Announces New Decision from Centers for Medicare & Medicaid Services Boosting CCTA Reimbursement and Access
November 1, 2024
Newsroom
Positive Long-term Outcomes with Heartflow FFRCT and Plaque Analysis Demonstrated in ADVANCE-DK Registry at TCT 2024
October 27, 2024
Newsroom
Heartflow Announces Favorable Coverage Determination for Plaque Analysis by Five Medicare Administrative Contractors
October 24, 2024
Newsroom
Heartflow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
October 18, 2024
Newsroom
Heartflow to Present Latest Data on AI-Enabled Coronary Artery Disease Management at TCT 2024
October 14, 2024
Newsroom
Heartflow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease
July 18, 2024
Newsroom
SCCT 2024: Heartflow to Present New Data on Coronary Artery Disease Management with Coronary Computed Tomography Angiography
July 16, 2024
Newsroom
Heartflow AI Plaque Analysis Achieves Major Milestone Towards Medicare Coverage
June 3, 2024
Newsroom
Heartflow’s Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study
May 15, 2024
Newsroom
Heartflow Announces Revolutionary Five-Year Data Demonstrating a 63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients
May 8, 2024
Newsroom
Heartflow Initiates DECIDE Registry to Evaluate Utility of Heartflow AI-Enabled Plaque Analysis for Patients with Suspected Coronary Artery Disease
March 26, 2024
Newsroom
Heartflow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journal of Cardiovascular Computed Tomography
March 12, 2024
Newsroom
Heartflow Announces New Reimbursement Code and Increased Payment for FFRCT
January 23, 2024
Newsroom
Heartflow Achieves Landmark Milestone of 250,000 Patients Assessed for Coronary Artery Disease with FFRCT Analysis
January 3, 2024

Newsroom
Heartflow Files for FDA Clearance of Next Generation Product Offering to Help Evaluate the Presence of Narrowings and Plaque in the Coronary Arteries
December 13, 2021
Newsroom
Heartflow Appoints Dr. Wayne J. Riley to its Board of Directors
November 15, 2021
Newsroom
CMS Sets National Payment Rate for the Heartflow Analysis in Doctors’ Offices and Imaging Centers
November 3, 2021
Newsroom
Heartflow Analysis is First AI-Enabled Technology to be Recognized by the American College of Cardiology and American Heart Association Guidelines as Important Tool in Diagnosing and Treating Heart Disease
October 28, 2021
Newsroom
Heartflow Announces Enrollment of First Two Patients in REVEALPLAQUE Trial
October 14, 2021
Newsroom
Heartflow Appoints John Farquhar as Chief Operating Officer
August 4, 2021
Newsroom
New 10-Year Data Demonstrate Superiority of the Heartflow Analysis in Predicting Long-Term Outcomes in Patients with Coronary Artery Disease
May 18, 2021
Newsroom
Heartflow Announces Completion of Patient Enrollment in the PRECISE Trial
May 11, 2021
Newsroom
Heartflow and MedAxiom Announce Collaboration to Improve Care Delivery for Patients with Coronary Artery Disease
May 5, 2021
Newsroom
NICE Renews Support for Use of AI-powered Heartflow Analysis in Heart Disease Diagnosis
April 26, 2021
Newsroom
New Medicare Local Coverage Determinations Published for the Heartflow Analysis
April 6, 2021
Newsroom
NHS England and NHS Improvement mandate adoption of AI-powered Heartflow Analysis to fight coronary heart disease
January 26, 2021

Discover how you can use Heartflow to advance your approach to coronary artery disease diagnosis, treatment and management.

Contact Us